Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

ORLANDO — A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic hand eczema achieved a “super-response,” by week 16, according to a presenter at the ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

Chronic stress floods the body with cortisol, triggering inflammation and weakening the immune system. Over time, this ...

She’s already spent more than a decade itching for a treatment that actually works for her.It was only last year that the ...

The visible symptoms only scratch the surface of this chronic skin condition Living with a chronic condition like atopic ...

Eczema is a chronic (long-lasting ... Dyshidrotic eczema symptoms usually appear on the hands and feet, and nickel and cobalt are major triggers. A dyshidrotic diet limits foods with a moderate ...

The initiative, aimed at making treatments for chronic diseases more accessible and affordable ... parts of the skin – its most recent launch was the Advanced Hand Balm for hand eczema in September ...

Eczema, on the other hand, is a chronic inflammatory skin condition that is associated with an impaired skin barrier. This is the outer layer of skin that protects your skin and prevents it from ...

Experts have used AI to produce images predicting how the average man and woman could look after exposure to microplastics.

Although it can be annoying, it typically doesn’t last too long. Eczema, on the other hand, is a long-term, chronic condition that needs ongoing treatment and symptom management. Although the ...

Stress may be a fact of life but burnout doesn’t have to be Your body and mind are giving you clues—are you listening Read ...